Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2011, Article ID 452729, 8 pages
http://dx.doi.org/10.1155/2011/452729
Research Article

Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma

1National AIDS Center, Istituto Superiore di Sanità, 00161 Rome, Italy
2Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy
3Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, Chicago, IL 60637, USA

Received 8 April 2011; Revised 18 July 2011; Accepted 24 July 2011

Academic Editor: Karlheinz Peter

Copyright © 2011 Cecilia Sgadari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Ensoli, C. Sgadari, G. Barillari, M. C. Sirianni, M. Stürzl, and P. Monini, “Biology of Kaposi's sarcoma,” European Journal of Cancer, vol. 37, no. 10, pp. 1251–1269, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. P. S. Moore and Y. Chang, “Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?” Annual Review of Microbiology, vol. 57, pp. 609–639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Ensoli, R. Gendelman, P. Markham et al., “Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma,” Nature, vol. 371, no. 6499, pp. 674–680, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Barillari, C. Sgadari, C. Palladino et al., “Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the α(v)β3 integrin,” Journal of Immunology, vol. 163, no. 4, pp. 1929–1935, 1999. View at Google Scholar · View at Scopus
  5. B. Ensoli, P. Markham, V. Kao et al., “Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS,” Journal of Clinical Investigation, vol. 94, no. 5, pp. 1736–1746, 1994. View at Google Scholar · View at Scopus
  6. G. Barillari and B. Ensoli, “Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 310–326, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Barillari, C. Sgadari, V. Fiorelli et al., “The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the α5β1 and αvβ3 integrins and by mobilizing sequestered basic fibroblast growth factor,” Blood, vol. 94, no. 2, pp. 663–672, 1999. View at Google Scholar · View at Scopus
  8. E. Kaaya, E. Castanos-Velez, T. Heiden et al., “Proliferation and apoptosis in the evolution of endemic and acquired immunodeficiency syndrome-related Kaposi's sarcoma,” Medical Oncology, vol. 17, no. 4, pp. 325–332, 2000. View at Google Scholar · View at Scopus
  9. C. B. Morris, R. Gendelman, A. J. Marrogi et al., “Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma,” American Journal of Pathology, vol. 148, no. 4, pp. 1055–1063, 1996. View at Google Scholar · View at Scopus
  10. S. Suster, C. Fisher, C. A. Moran, and A. M. Rywlin, “Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract,” American Journal of Surgical Pathology, vol. 22, no. 7, pp. 863–872, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Pillay, R. Chetty, and R. Reddy, “Bcl-2 and p53 immunoprofile in Kaposi's sarcoma,” Pathology and Oncology Research, vol. 5, no. 1, pp. 17–20, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. M. T. Fernández-Figueras, L. Puig, A. Fernández-Vasalo, M. Esquius, M. A. Montera, and A. Ariza, “Immunohistochemical detection of Bcl-2 in Kaposi's sarcoma lesions varies according to histopathologic stage, whereas expression of Bcl-x and Mcl-1 differs according to human immunodeficiency virus serologic status of patients,” Modern Pathology, vol. 13, no. 4, pp. 438–445, 2000. View at Google Scholar · View at Scopus
  13. G. Zauli, D. Gibellini, A. Caputo et al., “The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells,” Blood, vol. 86, no. 10, pp. 3823–3834, 1995. View at Google Scholar · View at Scopus
  14. K. J. Sastry, M. C. Marin, P. N. Nehete, K. McConnell, A. K. El-Naggar, and T. J. McDonnell, “Expression of human immunodeficiency virus type I tat results in downregulation of bcl-2 and induction of apoptosis in hematopoietic cells,” Oncogene, vol. 13, no. 3, pp. 487–493, 1996. View at Google Scholar · View at Scopus
  15. Z. Wang, G. F. Morris, J. C. Reed, G. D. Kelly, and C. B. Morris, “Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein,” Virology, vol. 257, no. 2, pp. 502–510, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. O. E. Pardo, A. Arcaro, G. Salerno, S. Raguz, J. Downward, and M. J. Seckl, “Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis,” Journal of Biological Chemistry, vol. 277, no. 14, pp. 12040–12046, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. S. H. Teh, A. K. Hill, D. A. Foley, E. W. McDermott, N. J. O'Higgins, and L. S. Young, “COX inhibitors modulate bFGF-induced cell survival in MCF-7 breast cancer cells,” Journal of Cellular Biochemistry, vol. 91, no. 4, pp. 796–807, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Saunders, M. B. Eldeen, L. Del Valle et al., “p73 modulates HIV-1 Tat transcriptional and apoptotic activities in human astrocytes,” Apoptosis, vol. 10, no. 6, pp. 1419–1431, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. O'Driscoll, D. Wallace, and T. G. Cotter, “bFGF promotes photoreceptor cell survival in vitro by PKA-mediated inactivation of glycogen synthase kinase 3β and CREB-dependent Bcl-2 up-regulation,” Journal of Neurochemistry, vol. 103, no. 3, pp. 860–870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Ohshima, Y. Yamaguchi, K. Kappert, P. Micke, and K. Otsuka, “bFGF rescues imatinib/STI571-induced apoptosis of sis-NIH3T3 fibroblasts,” Biochemical and Biophysical Research Communications, vol. 381, no. 2, pp. 165–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Tu, L. Dewachter, B. Gore et al., “Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 2, pp. 311–322, 2011. View at Google Scholar
  22. E. Fanales-Belasio, S. Moretti, V. Fiorelli et al., “HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection,” Journal of Immunology, vol. 182, no. 5, pp. 2888–2897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Munoz, Y. Zhou, and H. W. Jarrett, “LG4-5 domains of laminin-211 binds α-dystroglycan to allow myotube attachment and prevent anoikis,” Journal of Cellular Physiology, vol. 222, no. 1, pp. 111–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Toschi, G. Barillari, C. Sgadari et al., “Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 tat protein and basic fibroblast growth factor,” Molecular Biology of the Cell, vol. 12, no. 10, pp. 2934–2946, 2001. View at Google Scholar · View at Scopus
  25. J. B. Michel, “Anoïkis in the cardiovascular system: known and unknown extracellular mediators,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 12, pp. 2146–2154, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. P. Gilmore, “Anoikis,” Cell Death and Differentiation, vol. 12, no. 2, pp. 1473–1477, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Jiang, Z. Wang, H. Ganther, and J. Lu, “Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells,” Cancer Research, vol. 61, no. 7, pp. 3062–3070, 2001. View at Google Scholar · View at Scopus
  28. S. A. Eccles, “Parallels in invasion and angiogenesis provide pivotal points for therapeutic intervention,” International Journal of Developmental Biology, vol. 48, no. 5-6, pp. 583–598, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. J. E. Nör, J. Christensen, J. Liu et al., “Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth,” Cancer Research, vol. 61, no. 5, pp. 2183–2188, 2001. View at Google Scholar · View at Scopus
  30. Y. Sakai, S. Goodison, S. Kusmartsev et al., “Bcl-2 mediated modulation of vascularizationin prostate cancer xenografts,” Prostate, vol. 69, no. 5, pp. 459–470, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Cianfrocca, S. Lee, J. Von Roenn et al., “Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy,” Cancer, vol. 116, no. 16, pp. 3969–3977, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Sgadari, E. Toschi, C. Palladino et al., “Mechanism of paclitaxel activity in Kaposi's sarcoma,” Journal of Immunology, vol. 165, no. 1, pp. 509–517, 2000. View at Google Scholar · View at Scopus
  33. L. Zheng, Y. Yang, L. Guocai, C. D. Pauza, and M. S. Salvato, “HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand,” Intervirology, vol. 50, no. 3, pp. 224–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. E. A. Eugenin, J. E. King, A. Nath et al., “HIV-tat induces formation of an LRP-PSD-95-NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 9, pp. 3438–3443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Jajoo, D. Mukherjea, G. J. Brewer, and V. Ramkumar, “Pertussis toxin B-oligomer suppresses human immunodeficiency virus-1 Tat-induced neuronal apoptosis through feedback inhibition of phospholipase C-β by protein kinase C,” Neuroscience, vol. 151, no. 2, pp. 525–532, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. C. J. Li, D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee, “Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein,” Science, vol. 268, no. 5209, pp. 429–431, 1995. View at Google Scholar · View at Scopus
  37. S. F. Purvis, J. W. Jacobberger, R. M. Sramkoski, A. H. Patki, and M. M. Lederman, “HIV type 1 Tat protein induces apoptosis and death in Jurkat cells,” AIDS Research and Human Retroviruses, vol. 11, no. 4, pp. 443–450, 1995. View at Google Scholar · View at Scopus
  38. L. Qi, L. Gang, K. W. Hang et al., “Programmed neuronal cell death induced by HIV-1 tat and methamphetamine,” Microscopy Research and Technique. In press. View at Publisher · View at Google Scholar
  39. G. Zauli, D. Gibellini, D. Milani et al., “Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis,” Cancer Research, vol. 53, no. 18, pp. 4481–4485, 1993. View at Google Scholar · View at Scopus
  40. G. Barillari, R. Gendelman, R. C. Gallo, and B. Ensoli, “The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7941–7945, 1993. View at Google Scholar · View at Scopus
  41. E. Toschi, I. Bacigalupo, R. Strippoli et al., “HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway,” Molecular Biology of the Cell, vol. 17, no. 4, pp. 1985–1994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Kondo, D. Yin, T. Aoki, J. A. Takahashi, T. Morimura, and J. Takeuchi, “bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells,” Experimental Cell Research, vol. 213, no. 2, pp. 428–432, 1994. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Barillari, O. Franzese, A. Comandini, E. Bonmassar, and B. Ensoli, “Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors,” Oncology Reports, vol. 24, no. 1, pp. 219–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Barillari, O. Franzese, A. Iovane, and B. Ensoli, “Spindle cells from acquired immune deficiency syndrome-associated Kaposi's sarcoma lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor-2,” International Journal of Cancer, vol. 127, no. 10, pp. 2487–2489, 2010. View at Publisher · View at Google Scholar · View at Scopus